Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA

Karikó, Katalin, Buckstein, Michael, Ni, Houping, Weissman, Drew·2005·Immunity

Cited by (1,004)

Items 201–300 of 1,004

  1. Reprogramming human fibroblasts to pluripotency using modified mRNA
    P. Mandal, Derrick J. Rossi · 2013 · Nature Protocols
  2. RNA-Based Vaccines in Cancer Immunotherapy
    Megan Ann McNamara, Smita K. Nair, Eda K. Holl · 2015 · Journal of Immunology Research
  3. mRNA Delivery for Therapeutic Anti-HER2 Antibody Expression In Vivo
    Rybakova, Yulia, Kowalski, Piotr S., Huang, Yuxuan, Gonzalez, John T., Heartlein, Michael W., DeRosa, Frank, Delcassian, Derfogail, Anderson, Daniel G. · 2019 · Molecular Therapy
  4. An origin of the immunogenicity of in vitro transcribed RNA
    Mu, Xin, Greenwald, Emily, Ahmad, Sadeem, Hur, Sun · 2018 · Nucleic Acids Research
  5. Adjuvant-pulsed mRNA vaccine nanoparticle for immunoprophylactic and therapeutic tumor suppression in mice
    Mohammad Ariful Islam, Rice Jamie, Emma Reesor, Harshal R. Zope, Wei Tao, Michael Lim, Jianxun Ding, Yunhan Chen, Dike Aduluso, Bruce R. Zetter et al. · 2020 · Biomaterials
  6. Local delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models
    Christian Hotz, Timothy R. Wagenaar, Friederike Gieseke, Dinesh S. Bangari, Michelle Callahan, Hui Cao, Jan Diekmann, Mustafa Diken, Christian R. Grunwitz, Andy Hebert et al. · 2021 · Science Translational Medicine
  7. Engineering cytokine therapeutics
    Jeroen Deckers, Tom Anbergen, Ayla M. Hokke, Anne de Dreu, David P. Schrijver, Koen de Bruin, Yohana C. Toner, Thijs J. Beldman, Jamie B. Spangler, Tom F. A. de Greef et al. · 2023 · Nature Reviews Bioengineering
  8. Progress Toward In Vivo Use of siRNAs-II
    Garrett R. Rettig, Mark A. Behlke · 2011 · Molecular Therapy
  9. siRNA and isRNA: two edges of one sword
    Martin Schlee, Veit Hornung, Gunther Hartmann · 2006 · Molecular Therapy
  10. The Use of TLR7 and TLR8 Ligands for the Enhancement of Cancer Immunotherapy
    Evelien Smits, Peter Ponsaerts, Zwi Nisan Berneman, Viggo F. Van Tendeloo · 2008 · The Oncologist
  11. Toll-Like Receptor Expression and Induction of Type I and Type III Interferons in Primary Airway Epithelial Cells
    Ioannis Ioannidis, Fang Ye, Beth A. McNally, Meredith Willette, Emilio Flaño · 2013 · Journal of Virology
  12. Formulation and Delivery Technologies for mRNA Vaccines
    Chunxi Zeng, Chengxiang Zhang, Patrick G. Walker, Yizhou Dong · 2020 · Current topics in microbiology and immunology
  13. Naturally occurring modified ribonucleosides
    Phillip J. McCown, Agnieszka Ruszkowska, Charlotte N. Kunkler, Kurtis Breger, Jacob P. Hulewicz, Matthew C. Wang, Noah A. Springer, Jessica A. Brown · 2020 · Wiley Interdisciplinary Reviews - RNA
  14. Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
    Yingying Shi, Meixing Shi, Yì Wáng, Jian You · 2024 · Signal Transduction and Targeted Therapy
  15. Exploring Chemical Modifications for siRNA Therapeutics: A Structural and Functional Outlook
    Siddharth Shukla, Chintan S. Sumaria, Pushpangadan Indira Pradeepkumar · 2009 · ChemMedChem
  16. Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy
    Sandra Van Lint, Cleo Goyvaerts, Sarah K. Maenhout, Lode Goethals, Aurélie Disy, Daphné Benteyn, Joeri Jan Pen, Aude Bonehill, Carlo Heirman, Karine Breckpot et al. · 2012 · Cancer Research
  17. Induction of an IFN-mediated antiviral response by a self-amplifying RNA vaccine: implications for vaccine design
    Pepini, Timothy, Pulichino, Anne-Marie, Carsillo, Thomas, Carlson, Alicia L, Sari-Sarraf, Farid, Ramsauer, Katrin, Debasitis, Jason C, Maruggi, Giulietta, Otten, Gillis R, Geall, Andrew J et al. · 2017 · The Journal of Immunology
  18. Polymeric delivery systems for nucleic acid therapeutics: Approaching the clinic
    Annette I.S. van den Berg, Chae‐Ok Yun, Raymond Michel Schiffelers, Wim E. Hennink · 2021 · Journal of Controlled Release
  19. Emergence of synthetic mRNA: In vitro synthesis of mRNA and its applications in regenerative medicine
    Kwon, Hyokyoung, Kim, Minjeong, Seo, Yunmi, Moon, Yae Seul, Lee, Hwa Jeong, Lee, Kyuri, Lee, Hyukjin · 2018 · Biomaterials
  20. N6-methyl-adenosine modification in messenger and long non-coding RNA
    Tao Pan · 2013 · Trends in Biochemical Sciences
  21. Flavivirus Activation of Plasmacytoid Dendritic Cells Delineates Key Elements of TLR7 Signaling beyond Endosomal Recognition
    Jennifer P Wang, Ping Liu, Eicke Latz, Douglas Taylor Golenbock, Robert W. Finberg, Daniel H. Libraty · 2006 · The Journal of Immunology
  22. How mRNA therapeutics are entering the monoclonal antibody field
    Van Hoecke, Lien, Roose, Kenny · 2019 · Journal of Translational Medicine
  23. In Vitro Transcription of Long RNA Containing Modified Nucleosides
    Norbert Pardi, Hiromi Muramatsu, Drew Weissman, Katalin Karikó · 2012 · Methods in molecular biology
  24. Targeting and engineering long non-coding RNAs for cancer therapy
    Michela Coan, Simon Haefliger, Samir Ounzain, Rory Johnson · 2024 · Nature Reviews Genetics
  25. Transfer RNA and human disease
    Jamie A. Abbott, Christopher S. Francklyn, Susan M. Robey-Bond · 2014 · Frontiers in Genetics
  26. Sequence-non-specific effects of RNA interference triggers and microRNA regulators
    Marta Olejniczak, Paulina Galka-Marciniak, Włodzimierz J. Krzyżosiak · 2009 · Nucleic Acids Research
  27. A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection
    Kose, Nurgun, Fox, Julie M., Sapparapu, Gopal, Bombardi, Robin, Tennekoon, Rashika N., de Silva, A. Dharshan, Elbashir, Sayda M., Theisen, Matthew A., Humphris-Narayanan, Elisabeth, Ciaramella, Giuseppe et al. · 2019 · Science Immunology
  28. Biomaterials for vaccine-based cancer immunotherapy
    Rui Zhang, Margaret M. Billingsley, Michael J. Mitchell · 2018 · Journal of Controlled Release
  29. Toll-like receptor driven B cell activation in the induction of systemic autoimmunity
    N. Green, A. Marshak-Rothstein · 2011 · Seminars in Immunology
  30. iRNA(m6A)-PseDNC: Identifying N6-methyladenosine sites using pseudo dinucleotide composition
    Wei Chen, Hui Ding, Xu Zhou, Hao Lin, Kuo‐Chen Chou · 2018 · Analytical Biochemistry
  31. Safety Evaluation of Lipid Nanoparticle–Formulated Modified mRNA in the Sprague-Dawley Rat and Cynomolgus Monkey
    Sedic, Maja, Senn, Joseph J., Lynn, Andy, Laska, Michael, Smith, Mike, Platz, Stefan J., Bolen, Joseph, Hoge, Stephen, Bulychev, Alex, Jacquinet, Eric et al. · 2018 · Veterinary Pathology
  32. N6-methyladenosine modification and the YTHDF2 reader protein play cell type specific roles in lytic viral gene expression during Kaposi's sarcoma-associated herpesvirus infection
    Charles R. Hesser, John J. Karijolich, Dan Dominissini, Chuan He, Britt A. Glaunsinger · 2018 · PLoS Pathogens
  33. Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation
    Mustafa Diken, Sebastian Kreiter, Abderaouf Selmi, Cedrik Michael Britten, Christian G. Huber, Özlem Türeci, Uğur Şahin · 2011 · Gene Therapy
  34. Current prospects for mRNA gene delivery
    Ayako Yamamoto, Michael Kormann, Joseph Rosenecker, Carsten Rudolph · 2008 · European Journal of Pharmaceutics and Biopharmaceutics
  35. Toll-like receptor 3, RIG-I-like receptors and the NLRP3 inflammasome: Key modulators of innate immune responses to double-stranded RNA viruses
    Man Yu, Stewart J. Levine · 2011 · Cytokine & Growth Factor Reviews
  36. Silencing or Stimulation? siRNA Delivery and the Immune System
    Kathryn A. Whitehead, James E. Dahlman, Róbert Langer, Daniel G. Anderson · 2011 · Annual Review of Chemical and Biomolecular Engineering
  37. Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo
    Kevin J. Kauffman, Faryal F. Mir, Siddharth Jhunjhunwala, James C. Kaczmarek, Juan E. Hurtado, Jung H. Yang, Matthew J. Webber, Piotr S. Kowalski, Michael W. Heartlein, Frank DeRosa et al. · 2016 · Biomaterials
  38. Immortalization of primary microglia: a new platform to study HIV regulation in the central nervous system
    Yoelvis García‐Mesa, Taylor R. Jay, Mary Ann Checkley, Benjamin G. Luttge, Curtis N. Dobrowolski, Saba Valadkhan, Gary E. Landreth, Jonathan Karn, David Alvarez-Carbonell · 2016 · Journal of NeuroVirology
  39. Circular RNAs as Therapeutic Agents and Targets
    Lesca Miriam Holdt, Alexander Kohlmaier, Daniel Teupser · 2018 · Frontiers in Physiology
  40. Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
    Lulu Xue, Ningqiang Gong, Sarah J. Shepherd, Xinhong Xiong, Xueyang Liao, Xuexiang Han, Gan Zhao, Chao Song, Xisha Huang, Hanwen Zhang et al. · 2022 · Journal of the American Chemical Society
  41. RNA-binding protein YTHDF3 suppresses interferon-dependent antiviral responses by promoting FOXO3 translation
    Yuan Zhang, Xin Wang, Xiao Zhang, Jiaming Wang, Yuanwu Ma, Lianfeng Zhang, Xuetao Cao · 2018 · Proceedings of the National Academy of Sciences
  42. RNA: The new revolution in nucleic acid vaccines
    Andrew J. Geall, Christian W. Mandl, Jeffrey B. Ulmer · 2013 · Seminars in Immunology
  43. Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers
    Howell F. Moffett, Michael E. Coon, Stefan Radtke, Sirkka B. Stephan, Laura E. McKnight, Abigail R. Lambert, Barry L. Stoddard, Hans‐Peter Kiem, Matthias T. Stephan · 2017 · Nature Communications
  44. Clinical and immunological effects of mRNA vaccines in malignant diseases
    Annkristin Heine, Stefan Juranek, Peter Brossart · 2021 · Molecular Cancer
  45. Nucleic acid drugs: recent progress and future perspectives
    Xiaoyi Sun, Sarra Setrerrahmane, Chencheng Li, Jialiang Hu, Hanmei Xu · 2024 · Signal Transduction and Targeted Therapy
  46. Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy.
    Yu-Hua Wang, Hsing-Hao Su, Yang Yang, Yun-Xia Hu, Lu Zhang, P. Blancafort, Leaf Huang · 2013 · Molecular Therapy
  47. COVID-19, Myocarditis and Pericarditis
    Fairweather, DeLisa, Beetler, Danielle J., Di Florio, Damian N., Musigk, Nicolas, Heidecker, Bettina, Cooper, Leslie T. · 2023 · Circulation Research
  48. Extracellular and Intracellular Pattern Recognition Receptors Cooperate in the Recognition of Helicobacter pylori
    Roland Rad, Wibke Ballhorn, Petra Voland, Katharina Eisenächer, Jörg Mages, Lena Rad, Ruth Ferstl, Roland Lang, Hermann Wagner, Roland Michael Schmid et al. · 2009 · Gastroenterology
  49. Biocompatible, Purified VEGF-A mRNA Improves Cardiac Function after Intracardiac Injection 1 Week Post-myocardial Infarction in Swine
    Leif G. Carlsson, Jonathan C. Clarke, Christopher Yu Tai Yen, Francine M. Gregoire, Tamsin Albery, Martin A. Billger, Ann‐Charlotte Egnell, Li‐Ming Gan, Karin Jennbacken, Edvin Johansson et al. · 2018 · Molecular Therapy — Methods & Clinical Development
  50. Innate sensing of self and non-self RNAs by Toll-like receptors
    Mouldy Sioud · 2006 · Trends in Molecular Medicine
  51. M6APred-EL: A Sequence-Based Predictor for Identifying N6-methyladenosine Sites Using Ensemble Learning
    Wei, Leyi, Chen, Huangrong, Su, Ran · 2018 · Molecular Therapy Nucleic Acids
  52. TLR3 immunity to infection in mice and humans
    Shen‐Ying Zhang, Melina Casadio, Michael J. Ciancanelli, Rebeca Pérez de Diego, Vanessa Sancho‐Shimizu, Laurent Abel, Jean‐Laurent Casanova · 2013 · Current Opinion in Immunology
  53. Chemically Modified Platforms for Better RNA Therapeutics
    Yesi Shi, Xueyan Zhen, Yiming Zhang, Yongjiang Li, Seyoung Koo, Qimanguli Saiding, Na Kong, Gang Liu, Wei Chen, Wei Tao · 2024 · Chemical Reviews
  54. HPLC purification of in vitro transcribed long RNA
    Weissman, Drew, Pardi, Norbert, Muramatsu, Hiro, Karikó, Katalin · 2013 · Methods in molecular biology
  55. Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trials
    Jill Whitley, Christopher Zwolinski, Christian Denis, Maureen Maughan, Leonie Hayles, David Clarke, Meghan Snare, Hong Liao, Sean Chiou, Tina Marmura et al. · 2021 · Translational research
  56. Nanovector delivery of siRNA for cancer therapy
    Haifa Shen, Tianmeng Sun, Mauro Ferrari B · 2012 · Cancer Gene Therapy
  57. Adaptation and Constraint at Toll-Like Receptors in Primates
    Gabriela Wlasiuk, Michael W. Nachman · 2010 · Molecular Biology and Evolution
  58. Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs
    Stephanie Seneff, Greg Nigh, Anthony M. Kyriakopoulos, Peter Andrew McCullough · 2022 · Food and Chemical Toxicology
  59. Recent Advances in Lipid Nanoparticles for Delivery of mRNA
    Lei Yang, Liming Gong, Ping Wang, Xinghui Zhao, Feng Hua Zhao, Zhijie Zhang, Yunfei Li, Wei Huang · 2022 · Pharmaceutics
  60. Recent Advancement in mRNA Vaccine Development and Applications
    Nojoud AL Fayez, Majed Saeed Nassar, Abdullah Awad Alshehri, Meshal K. Alnefaie, Fahad A. Almughem, Bayan Y. Alshehri, Abdullah O. Alawad, Essam A. Tawfik · 2023 · Pharmaceutics
  61. Epigenetic and epitranscriptomic regulation of viral replication
    Kevin Tsai, Bryan R. Cullen · 2020 · Nature Reviews Microbiology
  62. Chemical Modifications to RNA: A New Layer of Gene Expression Regulation
    Jinghui Song, Chengqi Yi · 2017 · ACS Chemical Biology
  63. Prediction of lipid nanoparticles for mRNA vaccines by the machine learning algorithm
    Wei Wang, Shuo Feng, Zhuyifan Ye, Hanlu Gao, Jinzhong Lin, Defang Ouyang · 2021 · Acta Pharmaceutica Sinica B
  64. Importance of Nucleic Acid Recognition in Inflammation and Autoimmunity
    Franck J. Barrat, Keith B. Elkon, Katherine A. Fitzgerald · 2015 · Annual Review of Medicine
  65. mRNA cancer vaccines: Advances, trends and challenges
    Qing He, Hua Gao, Dejiang Tan, Heng Zhang, Junzhi Wang · 2022 · Acta Pharmaceutica Sinica B
  66. One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
    Dapeng Zhang, Elena N. Atochina‐Vasserman, Devendra S. Maurya, Ning Huang, Qi Xiao, Nathan A. Ona, Matthew Liu, Hamna Shahnawaz, Houping Ni, Kyunghee Kim et al. · 2021 · Journal of the American Chemical Society
  67. Research Advances on the Stability of mRNA Vaccines
    Feiran Cheng, Yi‐Ping Wang, Yu Bai, Zhenglun Liang, Qunying Mao, Dong Liu, Xing Wu, Miao Xu · 2023 · Viruses
  68. Roles of RNA Methylation on Tumor Immunity and Clinical Implications
    Maorun Zhang, Junmin Song, Weitang Yuan, Wei Zhang, Zhenqiang Sun · 2021 · Frontiers in Immunology
  69. Activation of immune signals during organ transplantation
    Qingwen Li, Peixiang Lan · 2023 · Signal Transduction and Targeted Therapy
  70. Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines
    Mohan Liu, Yusi Wang, Yi-Bing Zhang, Die Hu, Lin Tang, Bailing Zhou, Li Yang · 2025 · Signal Transduction and Targeted Therapy
  71. Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells
    Ofer Levy, Eugénie E. Suter, Richard Lloyd Miller, Michael R. Wessels · 2006 · Blood
  72. Analysis of RNA base modification and structural rearrangement by single-molecule real-time detection of reverse transcription
    Igor D. Vilfan, Yu‐Chih Tsai, Tyson A. Clark, Jeffrey Wegener, Qing Dai, Chengqi Yi, Tao Pan, Stephen W. Turner, Jonas Korlach · 2013 · Journal of Nanobiotechnology
  73. TLR7 Is Involved in Sequence-Specific Sensing of Single-Stranded RNAs in Human Macrophages
    Michael Paul Gantier, Stephen Y. C. Tong, Mark A. Behlke, Dakang Xu, Simon Phipps, Paul S. Foster, Bryan R.G. Williams · 2008 · The Journal of Immunology
  74. Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across
    Minnaert, An-Katrien, Vanluchene, Helena, Verbeke, Rein, Lentacker, Ine, De Smedt, Stefaan C., Raemdonck, Koen, Sanders, Niek N., Remaut, Katrien · 2021 · Advanced Drug Delivery Reviews
  75. Regulation of Viral Infection by the RNA Modification N6 -Methyladenosine
    Graham D. Williams, Nandan S. Gokhale, Stacy M. Horner · 2019 · Annual Review of Virology
  76. Gene therapy for the treatment of heart failure: promise postponed
    Hulot, Jean-Sebastien, Ishikawa, Kiyotake, Hajjar, Roger J. · 2016 · European Heart Journal
  77. Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic
    Samagra Jain, Abhijeet K. Venkataraman, Marissa E. Wechsler, Nicholas A. Peppas · 2021 · Advanced Drug Delivery Reviews
  78. Positive-sense RNA viruses reveal the complexity and dynamics of the cellular and viral epitranscriptomes during infection
    Will McIntyre, Rachel Netzband, Gaston Bonenfant, Jason M. Biegel, Clare M. Miller, Gabriele Fuchs, Eric Henderson, Manoj Arra, Mario Canki, Daniele Fabris et al. · 2018 · Nucleic Acids Research
  79. TIR, CARD and PYRIN: three domains for an antimicrobial triad
    Catherine Werts, Stephen E. Girardin, Dana J. Philpott · 2006 · Cell Death and Differentiation
  80. Delivering the right message: Challenges and opportunities in lipid nanoparticles-mediated modified mRNA therapeutics—An innate immune system standpoint
    Yasmin Granot-Matok, Dan Peer · 2017 · Seminars in Immunology
  81. Understanding RNA modifications: the promises and technological bottlenecks of the ‘epitranscriptome’
    Matthias Schaefer, Utkarsh Kapoor, Michael F. Jantsch · 2017 · Open Biology
  82. Decoding pseudouridine: an emerging target for therapeutic development
    Jonas Cerneckis, Qi Cui, Chuan He, Chengqi Yi, Yanhong Shi · 2022 · Trends in Pharmacological Sciences
  83. Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE)
    Hamideh Parhiz, Jacob S. Brenner, Priyal Patel, Tyler Ellis Papp, Hamna Shahnawaz, Qin Li, Ruiqi Shi, Marco E. Zamora, Amir Yadegari, Oscar Armando Marcos-Contreras et al. · 2021 · Journal of Controlled Release
  84. Roles for accessory molecules in microbial recognition by Toll-like receptors
    Kensuke Miyake · 2006 · Journal of Endotoxin Research
  85. RNAs as extracellular signaling molecules
    Marcel E. Dinger, Tim R. Mercer, John S. Mattick · 2008 · Journal of Molecular Endocrinology
  86. Suppression of immunostimulatory siRNA-driven innate immune activation by 2′-modified RNAs
    Mouldy Sioud, Gro Furset, Lina Cekaite · 2007 · Biochemical and Biophysical Research Communications
  87. ADAR RNA Modifications, the Epitranscriptome and Innate Immunity
    Jaclyn E. Quin, Jiří Sedmík, Dragana Vukić, Anzer Khan, Liam P. Keegan, Mary A. O’Connell · 2021 · Trends in Biochemical Sciences
  88. MicroRNAs as therapeutic targets in cardiovascular disease
    Bernhard Laggerbauer, Stefan Hanns Engelhardt · 2022 · Journal of Clinical Investigation
  89. Immunity to CRISPR Cas9 and Cas12a therapeutics
    Wei Leong Chew · 2017 · WIREs Systems Biology and Medicine
  90. N6-Methyladenosine modification of hepatitis B and C viral RNAs attenuates host innate immunity via RIG-I signaling
    Geon‐Woo Kim, Hasan Imam, Mohsin Ahmad Khan, Aleem Siddiqui · 2020 · Journal of Biological Chemistry
  91. MicroRNAs Prevent the Generation of Autoreactive Antibodies
    Laura Belver, Virginia G. de Yébenes, Almudena R. Ramiro · 2010 · Immunity
  92. Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice
    Jamile Ramos da Silva, Karine Bitencourt Rodrigues, Guilherme Formoso Pelegrin, Natiely Silva Sales, Hiromi Muramatsu, Mariângela de Oliveira Silva, Bruna F.M.M. Porchia, Ana Carolina Ramos Moreno, Luana R. M. M. Aps, Aléxia Adrianne Venceslau-Carvalho et al. · 2023 · Science Translational Medicine
  93. Tailor made: the art of therapeutic mRNA design
    Mihir Metkar, Christopher S. Pepin, Melissa J. Moore · 2023 · Nature Reviews Drug Discovery
  94. Therapeutic induction of antigen-specific immune tolerance
    Jessica E. Kenison, Nikolas A. Stevens, Francisco Javier Quintana · 2023 · Nature reviews. Immunology
  95. Phagosomal signaling by Borrelia burgdorferi in human monocytes involves Toll-like receptor (TLR) 2 and TLR8 cooperativity and TLR8-mediated induction of IFN-β
    Jorge Cervantes, Star M. Dunham-Ems, Carson J. La Vake, Mary M. Petzke, Bikash Sahay, Timothy J. Sellati, Justin David Radolf, Juan Carlos Salazar · 2011 · Proceedings of the National Academy of Sciences
  96. The identity and methylation status of the first transcribed nucleotide in eukaryotic mRNA 5’ cap modulates protein expression in living cells
    Sikorski, Pawel J, Warminski, Marcin, Kubacka, Dorota, Ratajczak, Tomasz, Nowis, Dominika, Kowalska, Joanna, Jemielity, Jacek · 2020 · Nucleic Acids Research
  97. Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency
    Prieve, Mary G., Harvie, Pierrot, Monahan, Sean D., Roy, Debashish, Li, Allen G., Blevins, Teri L., Paschal, Amber E., Waldheim, Matt, Bell, Eric C., Galperin, Anna et al. · 2018 · Molecular Therapy
  98. A network analysis of COVID-19 mRNA vaccine patents
    Mario A. Gaviria, Burcu Kilic · 2021 · Nature Biotechnology
  99. Biodegradable lipophilic polymeric mRNA nanoparticles for ligand-free targeting of splenic dendritic cells for cancer vaccination
    Elana Ben‐Akiva, Johan E. Karlsson, Shayan Hemmati, Hongzhe Yu, Stephany Yi Tzeng, Drew M. Pardoll, Jordan J. Green · 2023 · Proceedings of the National Academy of Sciences
  100. Population genetic tools for dissecting innate immunity in humans
    Lluís Quintana‐Murci, Andrew G. Clark · 2013 · Nature reviews. Immunology